107 related articles for article (PubMed ID: 15327590)
21. HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus.
Nakashima A; Nakashima R; Ito T; Masaki T; Yorioka N
Diabet Med; 2004 Sep; 21(9):1020-4. PubMed ID: 15317608
[TBL] [Abstract][Full Text] [Related]
22. Class effects of statins in elderly patients with congestive heart failure: a population-based analysis.
Rinfret S; Behlouli H; Eisenberg MJ; Humphries K; Tu JV; Pilote L
Am Heart J; 2008 Feb; 155(2):316-23. PubMed ID: 18215603
[TBL] [Abstract][Full Text] [Related]
23. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
[TBL] [Abstract][Full Text] [Related]
24. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
[TBL] [Abstract][Full Text] [Related]
25. Statins do not decrease the risk for wet age-related macular degeneration.
Kaiserman N; Vinker S; Kaiserman I
Curr Eye Res; 2009 Apr; 34(4):304-10. PubMed ID: 19373579
[TBL] [Abstract][Full Text] [Related]
26. Effect of statin adherence on cerebrovascular disease in primary prevention.
Perreault S; Ellia L; Dragomir A; Côté R; Blais L; Bérard A; Lalonde L
Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
[TBL] [Abstract][Full Text] [Related]
27. Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans.
Khurana V; Caldito G; Ankem M
Urology; 2008 Jan; 71(1):118-22. PubMed ID: 18242378
[TBL] [Abstract][Full Text] [Related]
28. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
[TBL] [Abstract][Full Text] [Related]
29. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
30. Effect of statins on the development of renal dysfunction.
Sukhija R; Bursac Z; Kakar P; Fink L; Fort C; Satwani S; Aronow WS; Bansal D; Mehta JL
Am J Cardiol; 2008 Apr; 101(7):975-9. PubMed ID: 18359317
[TBL] [Abstract][Full Text] [Related]
31. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant.
Peters BJ; Maitland-van der Zee AH; Stricker BH; van Wieren-de Wijer DB; de Boer A; Kroon AA; de Leeuw PW; Schiffers P; Janssen RG; van Duijn CM; Klungel OH
Pharmacogenet Genomics; 2008 Jul; 18(7):631-6. PubMed ID: 18551043
[TBL] [Abstract][Full Text] [Related]
33. Reduction in mortality associated with statin therapy in patients with severe sepsis.
Dobesh PP; Klepser DG; McGuire TR; Morgan CW; Olsen KM
Pharmacotherapy; 2009 Jun; 29(6):621-30. PubMed ID: 19476415
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for statin-associated rhabdomyolysis.
Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
Bradbury BD; Lash TL; Kaye JA; Jick SS
Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
[TBL] [Abstract][Full Text] [Related]
36. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
[TBL] [Abstract][Full Text] [Related]
37. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study.
Brauchli YB; Jick SS; Curtin F; Meier CR
J Am Acad Dermatol; 2008 Mar; 58(3):421-9. PubMed ID: 18194825
[TBL] [Abstract][Full Text] [Related]
38. Frequency of statin use in type 2 diabetics having macrovascular disease- at a Tertiary Care Hospital of Karachi.
Basit A; Hydrie MZ; Hakeem R; Ahmedani MY; Masood Q
J Ayub Med Coll Abbottabad; 2004; 16(4):60-4. PubMed ID: 15762067
[TBL] [Abstract][Full Text] [Related]
39. Statin use and the risk of incident dementia: the Cardiovascular Health Study.
Rea TD; Breitner JC; Psaty BM; Fitzpatrick AL; Lopez OL; Newman AB; Hazzard WR; Zandi PP; Burke GL; Lyketsos CG; Bernick C; Kuller LH
Arch Neurol; 2005 Jul; 62(7):1047-51. PubMed ID: 16009757
[TBL] [Abstract][Full Text] [Related]
40. Statin treatment and reduced risk of pneumonia in patients with diabetes.
van de Garde EM; Hak E; Souverein PC; Hoes AW; van den Bosch JM; Leufkens HG
Thorax; 2006 Nov; 61(11):957-61. PubMed ID: 16809409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
